Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,007,510 | 5,744,498 | 3,911,044 | 1,737,540 | 8,202,192 |
| Depreciation Amortization | N/A | 2,772,968 | 1,432,745 | 497,819 | 3,018,684 |
| Accounts receivable | N/A | N/A | N/A | N/A | -287,616 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 288,900 |
| Other Working Capital | N/A | -2,381,360 | -2,374,862 | -1,897,504 | 3,150,936 |
| Other Operating Activity | 3,927,280 | -365,410 | -700,298 | 118,594 | -3,534,856 |
| Operating Cash Flow | $10,934,790 | $5,770,696 | $2,268,629 | $456,449 | $10,838,240 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 79,756 | 92,386 | 93,653 | -56,539 | 3,668,388 |
| PPE Investments | -1,414,978 | -819,067 | -472,456 | -226,156 | -1,486,872 |
| Net Acquisitions | -24,752 | -34,473 | -25,160 | 4,137 | 351,816 |
| Purchase Of Investment | N/A | N/A | -1,398 | N/A | -5,136 |
| Sale Of Investment | 380,903 | 381,955 | 387,191 | N/A | N/A |
| Purchase Sale Intangibles | -1,357,224 | -1,504,380 | -266,980 | 241,325 | 310,728 |
| Other Investing Activity | -1,464,482 | -1,573,325 | -307,516 | 212,366 | 246,528 |
| Investing Cash Flow | $-2,443,553 | $-1,952,522 | $-325,687 | $-66,192 | $2,774,724 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 437,282 | N/A | N/A | N/A | -4,799,592 |
| Debt Issued | N/A | N/A | N/A | N/A | 4,234,632 |
| Common Stock Issued | 28,877 | 27,578 | 26,558 | 20,685 | 37,236 |
| Dividend Paid | -5,499,025 | -4,202,887 | -2,931,187 | -1,304,534 | -5,106,468 |
| Other Financing Activity | -5,402,764 | -2,464,094 | -1,877,245 | -613,655 | -7,375,298 |
| Financing Cash Flow | $-10,435,630 | $-6,639,403 | $-4,781,874 | $-1,897,504 | $-13,009,490 |
| Exchange Rate Effect | -39,878 | -28,957 | -47,525 | -48,265 | -50,076 |
| Beginning Cash Position | 7,235,776 | 7,254,393 | 7,353,826 | 7,256,298 | 6,203,004 |
| End Cash Position | 5,251,507 | 4,404,207 | 4,467,369 | 5,700,786 | 6,756,408 |
| Net Cash Flow | $-1,984,269 | $-2,850,186 | $-2,886,457 | $-1,555,512 | $553,404 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,934,790 | 5,770,696 | 2,268,629 | 456,449 | 10,838,240 |
| Capital Expenditure | -1,611,617 | -991,429 | -615,032 | -277,179 | -1,574,184 |
| Free Cash Flow | 9,323,173 | 4,779,267 | 1,653,597 | 179,270 | 9,264,056 |